A dried blood spot test for hepatitis B, C and AIDS
Tests dried blood spots for hepatitis and AIDS among drug users.
Key facts
- Who runs it
- University Hospital, Rouen
- Where
- Avranches, Barentin, Dieppe, Elbeuf, Gisors, Le Havre, Pont-Audemer, Rouen, and Yvetot, FranceSee the 11 sites
- Trial code
- Registry title
- Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot
- Status
- Recruiting
- People taking part
- 500 people, planned
- Started
- 2 Dec 2022
- Expected to end
- Jan 2027
- Type of study
- Interventional
- Treatments tested
- Blood collection using Dried Blood Spot
- Record updated
- 17 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who use or used drugs by injection or through the nose, or who are on opiate substitution treatment. They are screened for hepatitis B, hepatitis C and AIDS viruses with a dried blood spot.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Earlier treatment
- Current or former drug use by injection or through the nose, or being on opiate substitution therapy.
Main reasons for not taking part
- Known active viral infection
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Former or active intravenous and/or nasal drug user
- Person on opiate substitution therapy
Who cannot take part
- Person with known active viral infection(s)
Where in France
- Caarud Sud MancheAvranches, FranceContact: Laure Perrot, DrTaking people
- Csapa BarentinBarentin, FranceContact: Rémy Truchon, DrTaking people
- Oeuvre Normande Des MeresDieppe, FranceContact: Christian Piart, DrTaking people
- Csapa ActElbeuf, FranceContact: Olga Leclercq, DrTaking people
- Csapa GisorsGisors, FranceContact: Rémy Truchon, DrTaking people
- Csapa NautiliaLe Havre, FranceContact: Quentin Berthon, DrTaking people
- Csapa Pont-AudemerPont-Audemer, FranceContact: Marie-Claude Flavigny, DrTaking people
- Aides Region NormandieRouen, FranceContact: Julien Bord, DrTaking people
- CHU RouenRouen, FranceContact: Ghassan Riachi, DrTaking people
- Csapa-Caarud La BoussoleRouen, FranceContact: Véronique Michel, DrTaking people
- Csapa Caux Et BrayYvetot, FranceContact: Alexandre Hai, DrTaking people
About the trial
What the trial wants to find out
The aim of the study is to screen for hepatitis B, hepatitis C and AIDS viruses using a Dried Blood Spot in drug users
The group in the trial
- Drug userTreatment being tested
Drug users will be screened for Hepatitis C, Hepatitis B and AIDS using Dried Blood Spot for blood collection
Treatment: Blood collection using Dried Blood Spot
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot
- Plain-language title
- A dried blood spot test for hepatitis B, C and AIDSGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 17 February 2026